Medical Products meet osteoinductive bone graft needs.June 7, 2007 -
NuBone(TM) Osteoinductive Bone Graft product line includes 100% allograft tissue product, composed of osteoinductive demineralized bone matrix (DBM) combined with cortical bone gelatin carrier. Free of chemical additives and synthetics, NuBone DBM Putty and NuBone DBM Gel are designed for use in spinal fusion, trauma, and reconstructive bone grafting procedures. Aseptic manufacturing process maximizes osteoinductivity.
(Archive News Story - Products mentioned in this Archive News Story may or may not be available from the manufacturer.)
Original Press release
Globus Medical, Inc.
303 Schell Lane
Phoenixville, PA, 19460
USA
Globus Medical Introduces NuBone(TM) Osteoinductive Bone Graft Product Line
AUDUBON, Pa., May 11 -- Globus Medical, Inc., the largest privately-held spinal implant manufacturer in the world, announced the introduction of NuBone(TM) Osteoinductive Bone Graft product line. NuBone(TM) is a 100% allograft tissue product, composed of an osteoinductive demineralized bone matrix (DBM) combined with a unique cortical bone gelatin carrier. The first two products in the line to be released are NuBone DBM Putty and NuBone DBM Gel, developed for use in spinal fusion, trauma, and reconstructive bone grafting procedures.
"Since NuBone is derived entirely from cortical bone, it maintains a high level of osteoinductivity by avoiding the use of synthetic carriers that may negatively affect the long-term biological activity of DBM," stated neurosurgeon Dr. Akram Mahmoud, Medical Director of Neuroscience, Grant Medical Center, Columbus, Oh. "Globus has developed a composition completely free of chemical additives and synthetics, an aseptic manufacturing process to maximize osteoinductivity, and outstanding handling characteristics to facilitate usage by surgeons."
"NuBone marks Globus Medical's first foray into the Biomaterials segment," said Mark Borden, PhD, Director of Biomaterials, Globus Medical, Inc. "The Company plans several new biomaterials initiatives over the next 12 to 18 months. The Biomaterials Group at Globus has grown rapidly since its formation in July of 2005, and now includes a 14-member staff, onsite labs for biomaterials research and quality control testing, and extensive in-house manufacturing capabilities."
"Our entry into the Biomaterials segment is a further demonstration of the power of the Globus product development engine," remarked Glenn Kenney, Vice President, Strategy and Development, Globus Medical, Inc. "From a standing start less than two years ago, our Biomaterials Group has made significant progress on several innovative Biomaterials products, of which NuBone is only the first. Our Biomaterials Group is a key component in our strategy to innovate over a complete suite of products covering Fusion, MIS, Motion Preservation and Biomaterials."
About Globus Medical, Inc.
Globus Medical, Inc. is the largest privately-held spinal implant manufacturer in the world, with more than $100 million in annualized revenue. Based in Audubon, Pa., the company was founded in 2003 by an experienced team of spine professionals with a shared vision to create products that enable spine surgeons to employ both fusion and non-fusion solutions to promote healing in patients with spinal disorders. Globus Medical has a full portfolio of spinal fusion products, burgeoning initiatives in biomaterials development and minimally invasive approaches, and is among the world leaders in the development of motion preservation technologies. Additional information can be accessed at http://globusmedical.com/.
CONTACT: Barbara Link for Globus Medical, Inc., +1-610-668-2855, barbara@linkink.com
|
|
|
|
|
|
|
| 
